Alnylam Pharmaceuticals | ALNY - Текущие активы





Текущие активы Изменить Дата
Acadia Pharmaceuticals USD 1.22B 128.53M 2026-06
Agios Pharmaceuticals USD 717.67M 117.18M 2026-06
Alnylam Pharmaceuticals USD 4.62B 400.86M 2026-06
Amgen USD 34.96B 3.49B 2026-06
Arrowhead Research USD 1.67B 168.34M 2026-06
BioCryst Pharmaceuticals USD 484.68M 111.06M 2026-06
BioMarin Pharmaceutical USD 3.97B 633.45M 2026-06
Incyte USD 6.03B 542.31M 2026-06
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
Moderna USD 5.82B 45M 2026-06
Neurocrine Biosciences USD 1.64B 798.6M 2026-06
Novartis USD 26.61B 3.85B 2026-03
PTC Therapeutics USD 2.62B 363.36M 2026-06
Regeneron Pharmaceuticals USD 18.45B 236.8M 2026-06
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sanofi EUR 30.16B 789M 2026-03
Sarepta Therapeutics USD 2.22B 86.05M 2026-06
Takeda JPY 3.15T 59.77B 2026-06
Tectonic Therapeutic USD 239.89M 17.47M 2026-03
Ultragenyx Pharmaceutical USD 606M 51M 2026-06
Vertex Pharmaceuticals USD 12.54B 813.4M 2026-06
Xencor USD 523.21M 40.36M 2026-06